CLINICAL ASSISTED REPRODUCTION: Determination of the Efficiency of Controlled Ovarian Hyperstimulation in the Gonadotropin-Releasing Hormone Agonist-Suppression Cycle Using the Initial Follicle Count During Gonadotropin Stimulation

Gelijkaardige items

• Increased Progesterone/Estradiol Ratio on the Day of hCG Administration Adversely Affects Success of In Vitro Fertilization–Embryo Transfer in Patients Stimulated with Gonadotropin-releasing Hormone Agonist and Recombinant Follicle-stimulating Hormone
  door: Yu-Che Ou, et al.
  Gepubliceerd in: (2008-06-01)
• Clinical Assisted Reproduction: Antral Follicle Counting in Predicting the Retrieved Oocyte Number After Ovarian Hyperstimulation
  door: Hsieh, Yao-Yuan, et al.
  Gepubliceerd in: (2001)
• Expression of Insulin-Like Growth Factor (IGF), IGF Receptor, and IGF-Binding Protein Messenger Ribonucleic Acids in Luteinized Granulosa Cells from Different Size Follicles After Controlled Ovarian Hyperstimulation
  door: Chang, Shiuh Y., et al.
  Gepubliceerd in: (2002)
• Recombinant‐follicle stimulating hormone is more effective than urinary human menopausal gonadotropin in ovarian hyperstimulation for assisted reproductive technology treatment
  door: NAKAGAWA, KOJI, et al.
  Gepubliceerd in: (2007)
• A gonadotropin releasing hormone agonist trigger of ovulation with aggressive luteal phase support for patients at risk of ovarian hyperstimulation syndrome undergoing controlled ovarian hyperstimulation
  door: I-Ting Liang, et al.
  Gepubliceerd in: (2015-10-01)